Abstract
dibromo-1-(2-bromoethyl)indoline-2,3-dione and morpholine in DMF [ 1] .5 ,7-Dibromo-1-(2-morpholinoethyl)indoline-2,3-dione (0.5 mmol) was dissolved in 5m lo fe thanol and then an equimolar amount of methyl hydrazinecarbodithioate was added. The reaction mixture was stirred for 24 ha tr oom temperature. The seperated solid was collected by filtration and dried in air. The crude product was purified by recrystallization from DMF/ EtOH to give the title compound (yield 50%;m.p. 473-475 K). The yellow crystals of the title compound were obtained by slow evaporation of the mixture of methylene chloride and methanol (1:1).
Discussion
1H-indole-2,3-dione derivatives possess av ariety of biological activities, including antitumor activity [2] .I ntroduction of substituents at the 3-and 5-positions of the indolin-2-one ring have recently led to many derivatives possessing more potent antiumor activities [3, 4] .Inaddition, the introduction of an alkyl group or aryl group at the Natom of indolin-2-ones enhanced their cytotoxicity againstavarietyofcancercelllines [5, 6] . Herein, we report thecrystal structure of oneofthe derivateswhich maybea potential anticancer agent. The indolin-2-one ring system is substantially planar, and links to morpholine ring (chair conformation) via a-CH 2 -CH 2 -b ridge, in which the N2-C11-C12-N1 unit adopts a gauche conformation [torsion angle =-172.5(2)°]. The length of the double bond between C3 and N3 (1.288(4) Å) and the angle of N3-C3-C10 (128.1(3)°) are in agreement with those of analogous compounds reported [7, 8] . There is an intramolecular N4-H4···O2 hydrogen bond with the D···A distance of 2.738(2) Åa nd D-H···Aa ngleo f1 35.2°, which is responsible for the cis-configuration of the C3-N3 fragment. 
